Curis is a drug development company that is committed to leveraging its innovative signaling pathway drug technologies to seek to create new targeted small molecule drug candidates for cancer.
View Top Employees from Curis IncWebsite | http://www.curis.com/ |
Ticker | CRIS |
Revenue | $9 million |
Funding | $133.1 million |
Employees | 2 (2 on RocketReach) |
Founded | 2000 |
Address | 128 Spring St Ste 500, Lexington, Massachusetts 02421, US |
Phone | (617) 503-6500 |
Fax | (617) 503-6501 |
Category | Pharmaceutical Manufacturing, Pharmaceuticals, Healthcare |
Web Rank | 5 Million |
Keywords | curis, curis technologies, curis asco, curis cudc-101, curis pharma |
Competitors | Anavex Life Sciences, Aptahem, Cerecor, Inc., ManRos Therapeutics, Welichem Biotech Inc. |
SIC | 37, 28 |
NAICS | 54171, 541711, 325, 32, 325414, 5417, 3254, 541, 32541, 54 |
Looking for a particular Curis Inc employee's phone or email?
The Curis Inc annual revenue was $9 million in 2023.
2 people are employed at Curis Inc.
Curis Inc is based in Lexington, Massachusetts.
The NAICS codes for Curis Inc are [54171, 541711, 325, 32, 325414, 5417, 3254, 541, 32541, 54].
The SIC codes for Curis Inc are [37, 28].